keynote speaker
🇬🇧 Professor sir munir pirmohamed
MB ChB (Hons), MRCP, PhD, FRCP, FRCP (E), FBPharmacolS
Professor (Clin, Hcc) Pharmacology & Therapeutics
Professor Sir Munir Pirmohamed, holding the esteemed David Weatherall Chair in Medicine at the University of Liverpool, is a luminary figure in the realms of personalized medicine and drug safety. With a distinguished career spanning numerous prestigious roles and groundbreaking research endeavors, Professor Sir Munir Pirmohamed has left an indelible mark on the landscape of medical science.
- President of Association of Physicians, (2023)
- Chair of “Personalised Prescribing”, Royal College of Physicians (London) & British Pharmacological Society (2022)
- Chair of Commission on Human Medicine, (2021)
- David Weatherall Chair of Medicine, University of Liverpool, (2013)
- NHS Chair of Pharmacogenetics, (2007)
- Personal Chair in Clinical Pharmacology, University of Liverpool, (2001)
- Consultant Physician at Royal Liver University Hospital, (1996)
- Pharmacology (PhD), (1993)
Pioneering Leader in Personalized Medicine and Drug Safety
Professor Sir Munir Pirmohamed, holding the esteemed David Weatherall Chair in Medicine at the University of Liverpool, is a luminary figure in the realms of personalized medicine and drug safety. With a distinguished career spanning numerous prestigious roles and groundbreaking research endeavors, Professor Sir Munir Pirmohamed has left an indelible mark on the landscape of medical science.
academic & professional qualifications
As the NHS Chair of Pharmacogenetics and a Consultant Physician at the Royal Liverpool University Hospital, Professor Sir Munir Pirmohamed plays a pivotal role in bridging the gap between academia and clinical practice. His directorship of the Centre for Drug Safety Sciences and the Wolfson Centre for Personalized Medicine underscores his commitment to advancing innovative research and patient care.
Additionally, he serves as the Director of HDR North, contributing to collaborative efforts in health data research. Professor Sir Munir Pirmohamed’s exemplary contributions have earned him recognition as an inaugural NIHR Senior Investigator and a Fellow of the Academy of Medical Sciences in the UK. Furthermore, his appointment as a Commissioner on Human Medicines highlights his expertise and dedication to ensuring drug safety and efficacy.
leadership & impactful research
Professor Sir Munir Pirmohamed’s leadership extends beyond his academic and clinical roles. Having served as the President of the British Pharmacological Society and currently holding the presidency of the Association of Physicians, he has played a pivotal role in shaping healthcare policy and practice. His research in drug safety pharmacogenomics has had a profound clinical and scientific impact, particularly in the realm of abacavir hypersensitivity.
Through innovative trial designs and meticulous research, Professor Sir Munir Pirmohamed pioneered the implementation of genotyping for HLA-B*57:01, leading to the virtual disappearance of abacavir hypersensitivity globally. His dedication to furthering the field of stratified medicine continues to drive advancements in personalized healthcare. He was ranked number 1 expert in pharmacogenetics worldwide by Expertscape, included in the 2021 list of highly cited researchers by Clarivate, and published over 600 articles.
Recognition and Honors
In recognition of his outstanding contributions to healthcare and medical research, Professor Sir Munir Pirmohamed was bestowed with the Knights Bachelor in the Queen’s Birthday Honors in 2015. This prestigious honor is a testament to his unwavering dedication and groundbreaking achievements in the field of personalized medicine and drug safety.
- Sir Arthur Thomson Trust Lecture, 2023 (University of Birmingham, 2023)
- Prix Galien UK Chair 2023 – 2024 (PRIX GALIEN, 2023)
- President AOP (AOP, 2023)
- Honorary Fellowship of the British Pharmacological Society, 2022 (British Pharmacological Society, 2022)
- Bionow Outstanding Contribution Award, 2021 (BIONOW, 2021)
- President of BPS (BPS, 2020)
- Fellowship of the Royal Society of Biology, 2018 (Royal Society of Biology, 2018)
- Honorary Fellowship of the Faculty of Pharmaceutical Medicine, 2017 (Faculty of Pharmaceutical Medicine, 2017)
- Membership of Academia Europaea, 2016 (Academia Europaea, 2016)
- Andrew Duncan Lecture and Medal (Royal College of Physicians of Edinburgh, 2016)
- Knights Bachelor (Queen Birthday Honors List, 2015)
- William Withering Medal (Royal College of Physicians, 2014)
- Fellowship of the Academy of Medical Sciences, 2013 (Academy of Medical Sciences, 2013)
- IPIT Award for Public Service, 2011 (University of North Carolina, 2011)
- BPS Australasian Visitor (British Pharmacological Society, 2007)
- Fellowship (British Pharmacological Society, 2005)
- GSK Clinical Traveling Prize, 2002 (Warded by the British Pharmacological Society, 2002)
- BrAPP Prize. A for the “Best Young Investigator”, 1994 (The British Pharmacological Society, 1994)
- Department of Health NHS Chair of Pharmacogenomics, (Awarded 2007)
[National Institute for Health and Care Research (NIHR), 2007 – present] - NIHR Senior Investigator [National Institute for Health and Care Research (NIHR), 2008]
- Sir Desmond Pond Fellowship awarded by The Epilepsy Research Foundation (1992 – 1995)
- MRC Clinical Training Fellowship awarded by the Medical Research Council (1989 – 1992) [Medical Research Council (MRC), 1989 – 1992]